GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Position Lifted by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 30.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 61,729 shares of the company’s stock after buying an additional 14,321 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in GE HealthCare Technologies were worth $4,826,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of GEHC. OneDigital Investment Advisors LLC lifted its holdings in GE HealthCare Technologies by 7.5% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 13,798 shares of the company’s stock worth $1,295,000 after buying an additional 961 shares during the last quarter. Empowered Funds LLC lifted its holdings in shares of GE HealthCare Technologies by 30.7% in the 3rd quarter. Empowered Funds LLC now owns 23,470 shares of the company’s stock worth $2,203,000 after purchasing an additional 5,512 shares during the last quarter. Mutual of America Capital Management LLC lifted its holdings in shares of GE HealthCare Technologies by 5.0% in the 3rd quarter. Mutual of America Capital Management LLC now owns 56,349 shares of the company’s stock worth $5,288,000 after purchasing an additional 2,696 shares during the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of GE HealthCare Technologies by 16.5% in the 3rd quarter. Thrivent Financial for Lutherans now owns 25,408 shares of the company’s stock worth $2,385,000 after purchasing an additional 3,602 shares during the last quarter. Finally, Swiss National Bank lifted its holdings in shares of GE HealthCare Technologies by 0.5% in the 3rd quarter. Swiss National Bank now owns 1,287,187 shares of the company’s stock worth $120,802,000 after purchasing an additional 6,500 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on GEHC. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price target for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Finally, Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Stock Down 0.4 %

Shares of GEHC stock opened at $82.14 on Wednesday. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The stock has a market cap of $37.56 billion, a PE ratio of 18.97, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The business’s fifty day moving average is $87.25 and its 200-day moving average is $86.10. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.